$2.28 Billion is the total value of Rokos Capital Management LLP's 59 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | INVESCO QQQ TRput | $425,382,300 | -2.8% | 1,597,500 | 0.0% | 18.64% | +42.9% | |
| PINS | PINTEREST INCcall | $97,120,000 | +4.2% | 4,000,000 | 0.0% | 4.26% | +53.2% | |
| MSFT | MICROSOFT CORPput | $43,167,600 | +0.4% | 180,000 | 0.0% | 1.89% | +47.5% | |
| EWZ | ISHARES INCcall | $33,564,000 | -5.6% | 1,200,000 | 0.0% | 1.47% | +38.8% | |
| INTC | INTEL CORPcall | $26,430,000 | +2.6% | 1,000,000 | 0.0% | 1.16% | +50.8% | |
| FB | META PLATFORMS INCcall | $20,457,800 | -11.3% | 170,000 | 0.0% | 0.90% | +30.4% | |
| RPRX | ROYALTY PHARMA PLC | $19,312,566 | -3.0% | 492,228 | 0.0% | 0.85% | +42.7% | |
| ZTS | ZOETIS INCcl a | $18,070,035 | -3.8% | 124,052 | 0.0% | 0.79% | +41.4% | |
| GOOG | ALPHABET INCcap stk cl c | $16,852,599 | -11.2% | 192,140 | 0.0% | 0.74% | +30.4% | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $16,018,839 | +14.6% | 400,922 | 0.0% | 0.70% | +68.8% | |
| SGMO | SANGAMO THERAPEUTICS INC | $9,154,285 | -40.6% | 3,026,210 | 0.0% | 0.40% | -12.6% | |
| AR | ANTERO RESOURCES CORP | $8,058,839 | +0.6% | 263,533 | 0.0% | 0.35% | +47.7% | |
| PYPL | PAYPAL HLDGS INC | $7,628,652 | -21.0% | 108,300 | 0.0% | 0.33% | +16.0% | |
| BHC | BAUSCH HEALTH COS INC | $6,461,099 | -11.9% | 1,028,019 | 0.0% | 0.28% | +29.2% | |
| BG | BUNGE LIMITED | $5,426,408 | +19.8% | 54,721 | 0.0% | 0.24% | +76.3% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $3,485,125 | -40.6% | 87,500 | 0.0% | 0.15% | -12.6% | |
| REAL | THE REALREAL INC | $1,408,078 | -17.3% | 1,108,723 | 0.0% | 0.06% | +21.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC | 11 | Q3 2023 | 8.4% |
| ALPHABET INC | 10 | Q3 2023 | 12.8% |
| SALESFORCE INC | 10 | Q3 2023 | 3.6% |
| SNOWFLAKE INC | 10 | Q3 2023 | 1.6% |
| ALIBABA GROUP HLDG LTD | 9 | Q3 2023 | 34.2% |
| MICROSOFT CORP | 9 | Q3 2023 | 11.7% |
| SELECT SECTOR SPDR TR | 9 | Q3 2023 | 9.8% |
| PAYPAL HLDGS INC | 9 | Q3 2023 | 1.3% |
| CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 1.0% |
| SANGAMO THERAPEUTICS INC | 9 | Q3 2023 | 0.8% |
View Rokos Capital Management LLP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-17 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-15 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Rokos Capital Management LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.